Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response

Radiation therapy (RT) is frequently used to locally treat tumors. One of the major issues in RT is normal tissue toxicity; thus, it is necessary to limit dose escalation for enhanced local control in patients that have locally advanced tumors. Integrating radiosensitizing agents such as gold nanoparticles (GNPs) into RT has been shown to greatly increase the cure rate of solid tumors. The objective of this study was to explore the repurposing of an antimalarial drug, pyronaridine (PYD), as a DNA repair inhibitor to further enhance RT/GNP-induced DNA damage in cancerous cell lines. We were able to achieve inhibitory effects of DNA repair due to PYD at 500 nM concentration. Our results show a significant enhancement in DNA double-strand breaks of 42% in HeLa cells treated with PYD/GNP/RT in comparison to GNP/RT alone when irradiated with a dose of 2 Gy. Furthermore, there was a significant reduction in cellular proliferation for both HeLa and HCT-116 irradiated cells with the combined treatment of PYD/GNP/RT. Therefore, the emergence of promising novel concepts introduced in this study could lay the foundation for the transition of this treatment modality into clinical environments.

[1]  W. Beckham,et al.  Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel , 2022, Scientific Reports.

[2]  J. Karasinska,et al.  Potential of Gold Nanoparticles in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblasts Cells , 2022, Cancers.

[3]  K. Joshi,et al.  Prostate Apoptosis Response-4 (Par-4): A Novel Target in Pyronaridine-Induced Apoptosis in Glioblastoma (GBM) Cells , 2022, Cancers.

[4]  Ahmed H. Elmenoufy,et al.  Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains , 2022, Frontiers in Oncology.

[5]  W. Beckham,et al.  Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin , 2022, Pharmaceutics.

[6]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[7]  A. del Vecchio,et al.  Breast radiotherapy with kilovoltage photons and gold nanoparticles as radiosensitizer: An in vitro study , 2021, Medical physics.

[8]  J. Slabbert,et al.  Radiosensitization Effect of Gold Nanoparticles in Proton Therapy , 2021, Frontiers in Public Health.

[9]  E. Leung,et al.  Pyronaridine induces apoptosis in non‐small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor , 2021, Chemical biology & drug design.

[10]  W. Beckham,et al.  Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment , 2021, Cancers.

[11]  G. Francia,et al.  The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression In Vivo. , 2021, Clinical cancer drugs.

[12]  Ahmed H. Elmenoufy,et al.  Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair , 2021, Cancer Chemotherapy and Pharmacology.

[13]  Ahmed H. Elmenoufy,et al.  Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathway. , 2020, European journal of medicinal chemistry.

[14]  W. Beckham,et al.  Gold nanoparticle mediated radiation response among key cell components of the tumour microenvironment for the advancement of cancer nanotechnology , 2020, Scientific Reports.

[15]  D. Chithrani,et al.  Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine , 2020, Bioengineering.

[16]  Rutong Yu,et al.  Hypoxic Radiosensitizer-Lipid Coated Gold Nanoparticles Enhance the Effects of Radiation Therapy on Tumor Growth. , 2019, Journal of biomedical nanotechnology.

[17]  Ahmed H. Elmenoufy,et al.  Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPF. , 2019, Journal of medicinal chemistry.

[18]  J. Schuemann,et al.  Modulation of gold nanoparticle mediated radiation dose enhancement through synchronization of breast tumor cell population. , 2019, The British journal of radiology.

[19]  R. Hannan,et al.  Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Wayne Beckham,et al.  Optimization of uptake and transport of gold nanoparticles in two-dimensional and three-dimensional in-vitro cell models , 2019, BiOS.

[21]  G. Folkers,et al.  Function and Interactions of ERCC1-XPF in DNA Damage Response , 2018, Molecules.

[22]  Kathleen A Cronin,et al.  Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics , 2018, Cancer.

[23]  J. Schuemann,et al.  Determining the Radiation Enhancement Effects of Gold Nanoparticles in Cells in a Combined Treatment with Cisplatin and Radiation at Therapeutic Megavoltage Energies , 2018, Cancers.

[24]  D. Chithrani,et al.  Peptide Mediated In Vivo Tumor Targeting of Nanoparticles through Optimization in Single and Multilayer In Vitro Cell Models , 2018, Cancers.

[25]  M. Schwaiger,et al.  Exploring the Role of RGD-Recognizing Integrins in Cancer , 2017, Cancers.

[26]  Alaaldin M. Alkilany,et al.  Cellular uptake of nanoparticles: journey inside the cell. , 2017, Chemical Society reviews.

[27]  H. Shirato,et al.  Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells , 2017, International journal of nanomedicine.

[28]  Feihu Wang,et al.  pH, redox and photothermal tri-responsive DNA/polyethylenimine conjugated gold nanorods as nanocarriers for specific intracellular co-release of doxorubicin and chemosensitizer pyronaridine to combat multidrug resistant cancer. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[29]  Tanya M. Monro,et al.  Detection of gold nanoparticles with different sizes using absorption and fluorescence based method , 2016 .

[30]  Laura M Ensign,et al.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. , 2016, Advanced drug delivery reviews.

[31]  J. Uertz,et al.  Optimization of PEG coated nanoscale gold particles for enhanced radiation therapy , 2015 .

[32]  C. Cruje,et al.  Size-Dependent Gold Nanoparticle Interaction at Nano–Micro Interface Using Both Monolayer and Multilayer (Tissue-Like) Cell Models , 2015, Nano-micro letters.

[33]  S. Shave,et al.  Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance. , 2015, DNA repair.

[34]  B. Chithrani,et al.  Integration of Peptides for Enhanced Uptake of PEGylayed Gold Nanoparticles. , 2015, Journal of nanoscience and nanotechnology.

[35]  Hongbin Li,et al.  Quantifying thiol–gold interactions towards the efficient strength control , 2014, Nature Communications.

[36]  Ji-Ho Park,et al.  Endocytosis and exocytosis of nanoparticles in mammalian cells , 2014, International journal of nanomedicine.

[37]  C. Cruje,et al.  Polyethylene Glycol Functionalized Nanoparticles for Improved Cancer Treatment , 2014 .

[38]  Rolando Perez-Pineiro,et al.  Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells , 2013, Molecular Pharmacology.

[39]  Stefano Bonassi,et al.  γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. , 2013, Mutation research.

[40]  Anming Wang,et al.  The Functions and Applications of RGD in Tumor Therapy and Tissue Engineering , 2013, International journal of molecular sciences.

[41]  B. Jeremic,et al.  Radiosensitization by gold nanoparticles , 2013, Clinical and Translational Oncology.

[42]  D. Melton,et al.  DNA repair endonuclease ERCC1–XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy , 2012, Nucleic acids research.

[43]  N. McDonald,et al.  Fluorescence-based incision assay for human XPF–ERCC1 activity identifies important elements of DNA junction recognition , 2012, Nucleic acids research.

[44]  R. Baskar,et al.  Cancer and Radiation Therapy: Current Advances and Future Directions , 2012, International journal of medical sciences.

[45]  J. Rahn,et al.  Effects of varying gene targeting parameters on processing of recombination intermediates by ERCC1-XPF. , 2011, DNA repair.

[46]  Alan R Hounsell,et al.  Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. , 2011, International journal of radiation oncology, biology, physics.

[47]  Jin Hong,et al.  Size-dependent tissue kinetics of PEG-coated gold nanoparticles. , 2010, Toxicology and applied pharmacology.

[48]  Salomeh Jelveh,et al.  Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy , 2010, Radiation research.

[49]  Markus Löbrich,et al.  γH2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization , 2010, Cell cycle.

[50]  Xiaodong Zhang,et al.  Irradiation stability and cytotoxicity of gold nanoparticles for radiotherapy , 2009, International journal of nanomedicine.

[51]  L. Sanche,et al.  Gold Nanoparticles Enhance DNA Damage Induced by Anti-cancer Drugs and Radiation , 2009, Radiation research.

[52]  Michael S. Strano,et al.  Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. , 2009, ACS nano.

[53]  J. Hoeijmakers,et al.  ERCC1-XPF Endonuclease Facilitates DNA Double-Strand Break Repair , 2008, Molecular and Cellular Biology.

[54]  Yi Zheng,et al.  Role of secondary low-energy electrons in the concomitant chemoradiation therapy of cancer. , 2008, Physical review letters.

[55]  Ting Guo,et al.  Nanoscale energy deposition by X-ray absorbing nanostructures. , 2007, The journal of physical chemistry. B.

[56]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[57]  D. Fernig,et al.  Determination of size and concentration of gold nanoparticles from UV-vis spectra. , 2007, Analytical chemistry.

[58]  J. Loiseau,et al.  Electron beam transport in heterogeneous slab media from MeV down to eV. , 2006, Radiation protection dosimetry.

[59]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[60]  Geoff Delaney,et al.  The role of radiotherapy in cancer treatment , 2005, Cancer.

[61]  Huajian Gao,et al.  Mechanics of receptor-mediated endocytosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[63]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[64]  R. W. Fessenden,et al.  On the interactions of free radicals with gold nanoparticles. , 2003, Journal of the American Chemical Society.

[65]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[66]  L. Sanche.  Mechanisms of low energy electron damage to condensed biomolecules and DNA. , 2002, Radiation protection dosimetry.

[67]  D. Hunting,et al.  Cross Sections for Low-Energy (10 – 50 eV) Electron Damage to DNA , 2002, Radiation research.

[68]  P. McHugh,et al.  Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. , 2001, The Lancet. Oncology.

[69]  E. Illenberger,et al.  Sensitizing DNA to secondary electron damage: resonant formation of oxidative radicals from 5-halouracils. , 2001, Journal of the American Chemical Society.

[70]  Richard D. Wood,et al.  Repair of an Interstrand DNA Cross-link Initiated by ERCC1-XPF Repair/Recombination Nuclease* , 2000, The Journal of Biological Chemistry.

[71]  D. Hunting,et al.  Resonant formation of DNA strand breaks by low-energy (3 to 20 eV) electrons. , 2000, Science.

[72]  H Matsudaira,et al.  Iodine contrast medium sensitizes cultured mammalian cells to X rays but not to gamma rays. , 1980, Radiation research.

[73]  Ross Berbeco,et al.  Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization. , 2016, International journal of radiation oncology, biology, physics.

[74]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[75]  Yi Zheng,et al.  Radiosensitization of DNA by Gold Nanoparticles Irradiated with High-Energy Electrons , 2008, Radiation research.

[76]  J Winter,et al.  Radiation dose enhancement in tumors with iodine. , 1983, Medical physics.